March 09, 2022
Industry benefits from heightened innovation, site/sponsor relationships, and diversity.
August 01, 2016
An examination of recent failures in Phase III studies and innovative approaches to reduce risk.
June 01, 2005
A high-quality medical infrastructure and low costs make South Africa--largely an untapped opportunity--an attractive alternative for conducting clinical trials.